FRANKFURT Sun Feb 28, 2010 5:25pm EST Related News Merck revenue beats, confident on financial goalsTue, Feb 16 2010UPDATE 4-Merck revenue beats, confident on financial goalsTue, Feb 16 2010 Stocks & &
FRANKFURT (Reuters) - German pharmaceutical company Merck KGAA (MRCG.DE) said on Sunday it has entered into an agreement with Millipore (MIL.N) to acquire all of Millipore"s shares for $107 per share cash, valuing the deal at around $7.2 billion including net debt.
In a statement, Merck said the two companies would create a 2 billion euro entity for the life science sector.
"Due to the fact that the two businesses are highly complementary Merck expects that the transaction will clear regulatory review," the statement said.
Merck expects the deal will be completed in the second half of 2010.
Deals Inflows Outflows
No comments:
Post a Comment